News Search Results
Mar 31, 2026, 06:30 ET Keenova Announces Unaudited Fourth Quarter 2025 Financial Results
diversified brands portfolio, which is focused across a wide range of specialty therapeutic areas of significant unmet need. These include rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology, and neonatal respiratory critical care.Headquartered in Dublin, Ireland, Keenova
More news about: Keenova Therapeutics
Mar 30, 2026, 20:00 ET Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema
that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today announced that the company's partner Ollin reported final, 20-week study completion data from its randomized,
More news about: Innovent Biologics
Mar 30, 2026, 11:00 ET Applications for the 2026-2027 ABMS Scholars Program are Now Available
Member Boards: Allergy and Immunology, Anesthesiology, Dermatology, Emergency Medicine, Internal Medicine (Foundation), Obstetrics and Gynecology, Ophthalmology, Orthopaedic Surgery, Otolaryngology—Head and Neck Surgery, Pediatrics, Physical Medicine and Rehabilitation, Plastic Surgery, Radiology, Surgery,
More news about: American Board of Medical Specialties
Mar 30, 2026, 07:00 ET Vision Innovation Partners Acquires Frederick Eye Institute
that it has acquired Frederick Eye Institute, a comprehensive ophthalmology practice in Frederick, Maryland. This acquisition marks VIP's 28th add-on since its founding in 2017 and complements its growing network of ophthalmology practices. Led by Robert Bruce Hodges, MD, a board-certified
More news about: Vision Innovation Partners
Mar 27, 2026, 10:44 ET Sun Pharma Highlights Advances in Alopecia Areata, Psoriasis, and Acne Research at 2026 AAD Annual Meeting
company in the U.S. as well as global emerging markets. Sun Pharma's high-growth global specialty portfolio spans innovative products in dermatology, ophthalmology, and oncodermatology and accounts for over 18% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharma
Mar 27, 2026, 10:34 ET Better by MTA Expands Its Global Elite Network with Distinguished New Platinum Members
and is widely regarded as the most prestigious private hospital in Mexico.Board-certified by the Mexican Board of Ophthalmology and the International Council of Ophthalmology (ICO), Dr. Hindi has completed advanced international fellowship training in Cornea and Refractive Surgery, with further
More news about: Medical Tourism Association
Mar 27, 2026, 10:06 ET Better by MTA Expands Its Global Elite Network with Distinguished New Platinum Members
and is widely regarded as the most prestigious private hospital in Mexico.Board-certified by the Mexican Board of Ophthalmology and the International Council of Ophthalmology (ICO), Dr. Hindi has completed advanced international fellowship training in Cornea and Refractive Surgery, with further
More news about: Medical Tourism Association
Mar 27, 2026, 10:00 ET SightMD Pennsylvania Recognized as One of Berks County's Best Medical Professionals
www.sightmd.com or call 800.823.5530.SightMD Pennsylvania is actively seeking ophthalmology professionals who are interested in joining its outstanding team. If you are an ophthalmology practice owner interested in merging or selling your practice, please contact the Chief Medical Officer,
More news about: SightMD
Mar 27, 2026, 07:30 ET Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at the SHM Converge
diversified brands portfolio, which is focused across a wide range of specialty therapeutic areas of significant unmet need. These include rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology, and neonatal respiratory critical care.Headquartered in Dublin, Ireland, Keenova
More news about: Keenova Therapeutics
Mar 27, 2026, 05:38 ET Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026
Biocon focuses on areas of high unmet need, spanning key therapy areas including diabetes, oncology, obesity, cardiovascular diseases, immunology, ophthalmology, and bone health. The Company has pioneered several industry firsts that have helped shape the global biosimilars landscape. To date, the company
More news about: Biocon
Mar 26, 2026, 06:00 ET Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
meaningful", said Dr. Charles Wykoff, M.D., Ph.D, Chairman of Research, Retina Consultants of America and Professor of Clinical Ophthalmology and Deputy Chair of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital. "Multiple prior studies have demonstrated improvement in diabetic retinopathy
More news about: Kodiak Sciences Inc.
Mar 26, 2026, 06:00 ET Innovent Announces 2025 Annual Results and Business Updates
perspective.With Roche: Leveraging global oncology resources to advance IBI3009 (DLL3 ADC) worldwide.With Ollin: Utilizing global ophthalmology expertise to accelerate IBI324's clinical development and market positioning.High-Quality Manufacturing StandardsTotal
More news about: Innovent Biologics
Mar 25, 2026, 14:55 ET Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
Mar 25, 2026, 14:53 ET Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
Mar 25, 2026, 10:57 ET Orlando-Based Digital Space Marketing Pioneers AI-Powered Growth Engine for Cataract and LASIK Practices Nationwide
Full-service agency led by founder Clayton Patterson, Esq. combines specialized ophthalmology marketing expertise with proprietary AI platform Sollos AI to deliver an integrated ecosystem no competitor can replicateORLANDO, Fla.,
More news about: Digital Space Marketing
Mar 25, 2026, 09:00 ET Apotex Expands Canadian Ophthalmology Portfolio with Health Canada's Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)
formulated using nanoparticle technology to deliver a uniform, ophthalmic suspension. Its approval marks a meaningful enhancement to Apotex's growing ophthalmology portfolio and reinforces the Company's commitment to expanding access to treatment options for Canadian patients."As a Force for Health,
More news about: Apotex Inc.
Mar 25, 2026, 09:00 ET Luminopia Shows Promise in Improving Control of Intermittent Exotropia in Pilot Study
results were published in Ophthalmology, leading to the initial FDA approval for patients aged 4 to 7 years. Based on the robust real-world evidence collected through the PUPiL Registry,
More news about: Luminopia
Mar 24, 2026, 16:05 ET /C O R R E C T I O N -- Roche/
Across its Diagnostics and Pharmaceutical divisions, Roche focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology with the aim of providing real and positive change for patients, the people they love and the professionals
More news about: Roche
Mar 24, 2026, 15:27 ET /C O R R E C T I O N -- Roche/
Across its Diagnostics and Pharmaceutical divisions, Roche focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology with the aim of providing real and positive change for patients, the people they love and the professionals
More news about: Roche
Mar 24, 2026, 09:15 ET Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data
patient data in oncology, COTA complements Verana Health data and technology offerings across ophthalmology, urology, and neurology. The company is an exclusive partner of the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) and the American Urological Association
More news about: Verana Health
Mar 24, 2026, 09:00 ET ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
/PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, announced today the expansion of clinical workflows for ophthalmology and optometry in Canada, including advanced diagnostic equipment, new-generation laser treatment devices, and efficient digital workflow tools and
More news about: Carl Zeiss Meditec AG
Mar 24, 2026, 09:00 ET ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
/PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, announced today the expansion of clinical workflows for ophthalmology and optometry in Canada, including advanced diagnostic equipment, new-generation laser treatment devices, and efficient digital workflow tools and
More news about: Carl Zeiss Meditec AG
Mar 24, 2026, 08:30 ET InMode to Present at the 25th Annual Needham Virtual Healthcare Conference
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.Forward-Looking
More news about: InMode Ltd.
Mar 23, 2026, 20:00 ET The Phase 3 Registration STAR Study of Efdamrofusp Alfa (IBI302) Met its Primary Endpoint, Making it the First Self-developed Extended-interval Treatment for nAMD in China
journals.Professor Xiaodong Sun, Principal Investigator of the Study, Director of the Eye Center, Deputy Director of National Center for Clinical Ophthalmology, Deputy Director of Shanghai General Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, stated: " As the Principal Investigator,
More news about: Innovent Biologics
Mar 23, 2026, 07:00 ET Olympus Sells Retina Business of EyeSouth Partners
Carolina."We are immensely proud of Rex and the team for growing the business while remaining a patient-first, physician-led, medically focused ophthalmology platform," said Griffin Barstis, Partner at Olympus Partners. "Over the past several years, it became clear to our team that the optimal long-term
More news about: Olympus Partners